Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...

What if your doctor could, when you turn 65, order a test that predicts whether you are going to develop Alzheimer’s dementia in your 70s or 80s? And what if – in case the test comes back ...

Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer’s disease, the researchers observed how the loss of ADGRG1 led to the rapid buildup of ...

Roche has obtained European approval for a blood test to help rule out Alzheimer’s disease, allowing patients to avoid ...

Getting diagnosis, no matter how familiar the disease is can be a difficult process, filled with uncertainty and complex ...

Scientists have known for a while that Alzheimer’s disease affects some areas of the brain more than others. One key player ...

Bristol Myers Squibb has raided AstraZeneca to find its next chief medical officer (CMO), persuading Cristian Massacesi, M.D.

Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its SPEAR UltraDetect™ immunoassay solution. It delivers ...

How do U.S. president Donald Trump's sleep patterns affect his overall health? Based on his social media posts, we can assume ...

MRI findings indicate that smoking is linked to reduced brain volume, raising concerns about dementia risk, especially with ...

Vaccines to prevent infection − including the COVID vaccine − might be as important as anything you might do to maintain your brain health.